SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (45)11/1/2000 2:28:29 PM
From: Biomaven  Read Replies (3) | Respond to of 1784
 
tuck,

I guess my view is that you should stick with "paradigmatic" trickle stocks - those whose performance over the next year or so will be driven by the extent to which they show up in the accounts payable of the biotech and pharma companies. I like IGEN, but like KDUS it's not really a trickle stock. There's enough to choose from without getting tempted by stocks whose price is going to be driven mostly by other factors.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News